2025-522826-11-00Active, not recruitingPhase 1/2
Longitudinal study with positron emission tomography using [18F]PI-2620 in primary tauopathies. Proof-of-concept study
Source: EU CTIS (euclinicaltrials.eu) · Last updated 13 Apr 2026
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- First submitted
- 14 Jul 2025
- Start date
- 6 Nov 2025
- Lead sponsor
- ZRO Imaging AB
- Diseases
- Frontotemporal dementia
- EU CT number
- 2025-522826-11-00
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 64
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Complexo Hospitalario Universitario De Santiago | Santiago de Compostela | Spain | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.